Myotonic dystrophy type 1 (DM1) impacts women’s health in several ways, causing gynecological and obstetrical issues, among others. Documenting the frequency and severity of these clinical issues is crucial for improving the care and health-related quality of life of women with DM1. This scoping review aimed to map and describe existing research on gynecological and obstetrical issues in women with DM1 and identify research gaps.
Methods:
Comprehensive searches were conducted across multiple databases, including PubMed, CINAHL, ProQuest Central, and Google Scholar, from inception to December 2023. Studies examining gynecological and obstetrical issues in women with DM1 using quantitative, qualitative, and mixed methods were included. Two authors independently screened studies and extracted data using standardized forms.
Results:
A total of 36 studies were included. Gynecological problems in women with DM1 included fertility issues, genital malignancies, and pelvic floor disorders, while obstetrical complications entailed miscarriage, ectopic pregnancy, preeclampsia, hypertensive disease, polyhydramnios, preterm labor, and nonvertex presentation.
Conclusion:
This scoping review demonstrates that few articles document gynecological and obstetrical issues in women with DM1. Future studies should address this important knowledge gap and enhance management and outcomes for these women.
LiaoQ, ZhangY, HeJ, et al.Global prevalence of myotonic dystrophy: An updated systematic review and meta-analysis. Neuroepidemiology2022;56(3):163–173; doi: 10.1159/000524734
2.
PrévostC. Pregnancy outcome of women with myotonic dystrophy. Neurology1992;42(3):228.
3.
SrebnikN, MargaliothEJ, RabinowitzR, et al.Ovarian reserve and PGD treatment outcome in women with myotonic dystrophy. Reprod Biomed Online2014;29(1):94–101; doi: 10.1016/j.rbmo.2014.03.013
4.
RanumLPW, DayJW. Myotonic dystrophy: RNA pathogenesis comes into focus. Am J Hum Genet2004;74(5):793–804; doi: 10.1086/383590
5.
ChoDH, TapscottSJ. Myotonic dystrophy: Emerging mechanisms for DM1 and DM2. Biochim Biophys Acta2007;1772(2):195–204; doi: 10.1016/j.bbadis.2006.05.013
López-MartínezA, Soblechero-MartínP, de-la-Puente-OvejeroL, et al.An overview of alternative splicing defects implicated in myotonic dystrophy type I. Genes (Basel)2020;11(9):1109; doi: 10.3390/genes11091109
9.
De AntonioM, DoganC, HamrounD, French Myotonic Dystrophy Clinical Networket al.;. Unravelling the myotonic dystrophy type 1 clinical spectrum: A systematic registry-based study with implications for disease classification. Rev Neurol (Paris)2016;172(10):572–580; doi: 10.1016/j.neurol.2016.08.003
10.
ParmovaO, VlckovaE, HulovaM, et al.Anti-müllerian hormone as an ovarian reserve marker in women with the most frequent muscular dystrophies. Medicine (Baltimore)2020;99(23):e20523; doi: 10.1097/MD.0000000000020523
11.
HarveyJC, SherbourneDH, SiegelCI. Smooth muscle involvement in myotonic dystrophy. Am J Med1965;39(1):81–90; doi: 10.1016/0002-9343(65)90247-0
12.
AwaterC, ZerresK, Rudnik-SchönebornS. Pregnancy course and outcome in women with hereditary neuromuscular disorders: Comparison of obstetric risks in 178 patients. Eur J Obstet Gynecol Reprod Biol2012;162(2):153–159; doi: 10.1016/j.ejogrb.2012.02.020
13.
Rudnik-SchönebornS, NicholsonGA, MorganG, et al.Different patterns of obstetric complications in myotonic dystrophy in relation to the disease status of the fetus. Am J Med Genet1998;80(4):314–321; doi: 10.1002/(SICI)1096-8628(19981204)80:4<314::AID-AJMG3>3.0.CO;2-I
14.
Rudnik-SchönebornS, ZerresK. Outcome in pregnancies complicated by myotonic dystrophy: A study of 31 patients and review of the literature. Eur J Obstet Gynecol Reprod Biol2004;114(1):44–53; doi: 10.1016/j.ejogrb.2003.11.025
15.
Fernández-TorrónR, García-PugaM, EmparanzaJI, et al.Cancer risk in DM1 is sex-related and linked to miRNA-200/141 downregulation. Neurology2016;87(12):1250–1257; doi: 10.1212/WNL.0000000000003124
AlsaggafR, St GeorgeDMM, ZhanM, et al.Benign tumors in myotonic dystrophy type I target disease-related cancer sites. Ann Clin Transl Neurol2019;6(8):1510–1518; doi: 10.1002/acn3.50856
18.
AlsaggafR, St GeorgeDMM, ZhanM, et al.Cancer risk in myotonic dystrophy type I: Evidence of a role for disease severity. JNCI Cancer Spectr2018;2(4):pky052; doi: 10.1093/jncics/pky052
19.
Fisette-PaulhusI, GagnonC, MorinM. Prevalence of urinary incontinence and other pelvic floor disorders in women with myotonic dystrophy type 1. Neuromuscul Disord2023;33(1):32–39; doi: 10.1016/j.nmd.2022.11.003
20.
VerpoestW, SenecaS, De RademaekerM, et al.The reproductive outcome of female patients with myotonic dystrophy type 1 (DM1) undergoing PGD is not affected by the size of the expanded CTG repeat tract. J Assist Reprod Genet2010;27(6):327–333; doi: 10.1007/s10815-010-9392-9
21.
JohnsonNE, HungM, NasserE, et al.The impact of pregnancy on myotonic dystrophy: A registry-based study. J Neuromuscul Dis2015;2(4):447–452; doi: 10.3233/jnd-150095
22.
BesantG, BourquePR, SmithIC, et al.Case report: Severe peripartum cardiac disease in myotonic dystrophy type 1. Front Cardiovasc Med2022;9(899606):899606; doi: 10.3389/fcvm.2022.899606
23.
KataokaH, UenoS. A giant uterine tumor in a woman with myotonic dystrophy. Clin Case Rep2017;5(4):539–540; doi: 10.1002/ccr3.864
24.
AtlasI, SmolinA. Combined maternal and congenital myotonic dystrophy managed by a multidisciplinary team. Eur J Obstet Gynecol Reprod Biol1999;87(2):175–178; doi: 10.1016/s0301-2115(99)00105-0
25.
SahuB, OzturkO, DeoN, et al.Response to controlled ovarian stimulation and oocyte quality in women with myotonic dystrophy type I. J Assist Reprod Genet2008;25(1):1–5; doi: 10.1007/s10815-007-9193-y
26.
FernándezRM, Lozano-AranaMD, SánchezB, et al.Preimplantation genetic diagnosis for myotonic dystrophy type 1 and analysis of the effect of the disease on the reproductive outcome of the affected female patients. Biomed Res Int2017;2017:9165363; doi: 10.1155/2017/9165363
27.
FebresF, ScagliaH, LiskerR, et al.Hypothalamic-pituitary-gonadal function in patients with myotonic dystrophy. J Clin Endocrinol Metab1975;41(5):833–840; doi: 10.1210/jcem-41-5-833
28.
KinoshitaM, IgarashiA, KomoriT, et al.Differences in CTG triplet repeat expansions in an ovarian cancer and cyst from a patient with myotonic dystrophy. Muscle Nerve1997;20(5):622–624; doi: 10.1002/(sici)1097-4598(199705)20:5<622::aid-mus16>3.0.co;2-y
DorcierLM, CoatlevenF, MadarH, et al.Abnormally invasive placentation in a woman with congenital myotonic dystrophy. Int J Gynaecol Obstet2018;140(3):376–377; doi: 10.1002/ijgo.12363
31.
O’ConnorPJ, CaldicottLD, BraithwaiteP. Urgent caesarean section in a patient with myotonic dystrophy: A case report and review. Int J Obstet Anesth1996;5(4):272–274; doi: 10.1016/s0959-289x(96)80050-1
D’AmbrosioES, Gonzalez-PerezP. Cancer and myotonic dystrophy. J Clin Med2023;12(5):1939; doi: 10.3390/jcm12051939
34.
MuellerCM, HilbertJE, MartensW, et al.Hypothesis: Neoplasms in myotonic dystrophy. Cancer Causes Control2009;20(10):2009–2020; doi: 10.1007/s10552-009-9395-y
35.
AhmedHS, TeliA, KhullarK, et al.Maternal health and obstetric complications of genetic neuromuscular disorders in pregnancy: A systematic review. Eur J Obstet Gynecol Reprod Biol2025;304:152–170; doi: 10.1016/j.ejogrb.2024.11.046
36.
Passos-BuenoMR, CerqueiraA, VainzofM, et al.Myotonic dystrophy: Genetic, clinical, and molecular analysis of patients from 41 Brazilian families. J Med Genet1995;32(1):14–18; doi: 10.1136/jmg.32.1.14
37.
DaoT-N, MathieuJ, BouchardJ-P, et al.Fertility in myotonic dystrophy in Saguenay-Lac-St-Jean: A historical perspective. Clin Genet1992;42(5):234–239; doi: 10.1111/j.1399-0004.1992.tb03247.x
38.
FernándezRM, Lozano-AranaMD, SánchezB, et al.Preimplantation genetic diagnosis for myotonic dystrophy type 1 and analysis of the effect of the disease on the reproductive outcome of the affected female patients. Biomed Res Int2017;2017(9165363):9165363; doi: 10.1155/2017/9165363
39.
KohEY, van KesterenPJ. Two cases of endometrial cancer in twin sisters with myotonic dystrophy. Case Rep Obstet Gynecol2016;2016:9737014; doi: 10.1155/2016/9737014
40.
VarrasM, PolyzosD, AlexopoulosC, et al.Torsion of a non-gravid leiomyomatous uterus in a patient with myotonic dystrophy complaining of acute urinary retention: Anaesthetic management for total abdominal hysterectom. Clin Exp Obstet Gynecol2003;30(2–3):147–150; doi: 10.1016/S0301-2115(01)00334-7
41.
RisseeuwJJ, OudshoornJH, van der StraatenPJ, et al.Myotonic dystrophy in pregnancy: A report of two cases within one family. Eur J Obstet Gynecol Reprod Biol1997;73(2):145–148; doi: 10.1016/s0301-2115(97)02747-4
42.
DelestA, ElhageA, CossonM, et al.[Steinert’s disease and pregnancy. A case report and recent literature]. J Gynecol Obstet Biol Reprod (Paris)1995;24(2):177–180.
43.
WalpoleAR, RossAW. Acute cord prolapse in an obstetric patient with myotonia dystrophica. Anaesth Intensive Care1992;20(4):526–528; doi: 10.1177/0310057X9202000429
44.
FreemanRM. Placenta accreta and myotonic dystrophy. Two case reports. Br J Obstet Gynaecol1991;98(6):594–595; doi: 10.1111/j.1471-0528.1991.tb10378.x
ParisG, LaframboiseR, BouchardJP. [The mother and infant with Steinert’s myotonic dystrophy]. Can J Neurol Sci1989;16(1):104–108.
47.
ChungHT, TamAY, WongV, et al.Dystrophia myotonica and pregnancy - an instructive case. Postgrad Med J1987;63(741):555–557; doi: 10.1136/pgmj.63.741.555
48.
ArulkumaranS, RauffM, IngemarssonI, et al.Uterine activity in myotonia dystrophica. Case report. Br J Obstet Gynaecol1986;93(6):634–636; doi: 10.1111/j.1471-0528.1986.tb08039.x
KhanZA, KhanSAA. Myotonic dystrophy and pregnancy. J Pak Med Assoc2009;59(10):717–719.
51.
DufourP, BerardJ, VinatierD, et al.Myotonic dystrophy and pregnancy. A report of two cases and a review of the literature. Eur J Obstet Gynecol Reprod Biol1997;72(2):159–164; doi: 10.1016/s0301-2115(96)02690-5
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
